Navigation Links
Synthetic protein found to relieve arthritis symptoms in animal model

A synthetic version of a human protein has been found to alleviate symptoms associated with acute and chronic arthritis in mice, which could be the basis for developing a new drug for the disease, according to researchers. // The protein has been found to function by blocking the transmission of chemical signals associated with development of arthritis symptoms.

The idea that the protein, called pre-ligand assembly domain protein or PLAD, might play a role in easing or comforting pain characteristic of rheumatoid arthritis is an incidental discovery. The original work was carried out on a very rare autoimmune disease called autoimmune lymphoproliferative syndrome (ALPS).

Previously, it has been shown that PLAD blocks a cell surface receptor and prevents a needed chemical signaling pathway from functioning correctly. In ALPS, the signal pathway interrupted by PLAD leads to disease symptoms. But, the scientists reasoned, PLAD might also be able to block a related cell surface receptor one involved in passing signals, leading to inflammation. In theory, inhibiting this pathway might benefit people with rheumatoid arthritis, who suffer from excessive inflammation.

The scientists used a variety of techniques to induce arthritis symptoms in mice. Researchers also injected some of the animals with lab-made PLAD (P60 PLAD). It was found that P60 PLAD protein powerfully inhibited the symptoms of TNF-alpha-induced arthritis (a key promoter of inflammation is a chemical called tumor necrosis factor alpha- TNF-alpha). Moreover, it also appeared to inhibit disease symptoms in mice with established as well as acute arthritis. The scientists did not detect any obvious toxicity in the PLAD-treated mice.

The scientist’s next aim is to develop a more stable form of P60 PLAD to be followed by testing of the protein in clinical trials. This study opens a new research avenue to better understand and, perhaps, to treat rheumatoid arthritis,
'"/>




Page: 1 2

Related medicine news :

1. New Study Will The Look Into The Effects Of Synthetic Steroids
2. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
3. A Synthetic Molecule Instigates Cancer Cells To Self-Harm
4. Synthetic DNA Makes Better Hydrogels for Drug Delivery
5. Super Chow, Laced With Semi-Synthetic Vitamin E, Inhibited Spread of Cancer
6. Synthetic Chemicals May Trigger Breast Cancer
7. Synthetic Cannabinoid Could Improve Fertility in Smokers
8. Chemicals Used To Make Synthetic Color Can Cause Cancer And Permanent Blindness
9. Special proteins to fight TB identified
10. High-protein diets may pose health risks
11. Hidden influenza virus protein found

Post Your Comments:
(Date:12/2/2009)...ew Directors Represent Diverse Healthcare Stakehol...swire/ -- The membership of the National Quality F...f Directors and reappointed four current Board mem... of healthcare stakeholders, including consumers, ...d community healthcare. ,, The newly elected B...
(Date:12/2/2009)...ec. 2 Independence Blue Cross (IBC... with Lincoln Financial Group. IBC will be the pri...y 10,000 Lincoln Financial Group employees, retire...ncoln plan offerings will include the PPO option a...w I speak for all of us at Independence Blue Cross...
(Date:12/2/2009)...ers from the California Institute of Technology (C...the first time, the previously mysterious process ... are added by enzymes called ubiquitin ligases to ...ains tag target proteins for destruction by protei...hat ubiquitin ligases build ubiquitin chains very ...
(Date:12/2/2009)...ial congress of the European Association of Echoca...ean Society of Cardiology, where techniques of non..., New case reports will be presented at this year... the role of this new technology. , Now, with s... likely that non-invasive imaging will gain more i...
(Date:12/2/2009)... First Aid has been a top name in the medical supp...lity products, professional staff, and a keen unde...irst Aid has established itself as a provider of g...s a first aid supplies distributor. The distinguis...ter into its next phase with the redesign and laun...
Breaking Medicine News(10 mins):Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:Media alert: EUROECHO 2009 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3
...nicians who don,t know about studies won,t use fin...3 (HealthDay News) -- About 25 percent of practici... two major federal government-funded clinical tria...s and rheumatologists, also found that many clinic...
...ptians may have been using herb-spiked drink for h...3 (HealthDay News) -- The old adage, "take a glass...eded more than 5,000 years ago in ancient Egypt, a...e wine had been steeped in herbs including balm, c...
... KINGSTON, R.I. April 14, 2009 Most fish rely pr... but a University of Rhode Island biologist and he...ican cichlids feeds by using its lateral line sens... along the side of the body of a fish, around its ...
...emonstrates Potential Benefits of Stimulus Package...l care patients at seven Resurrection Health Care ...ications and have extended intensive care unit (IC...08 at 13 Resurrection ICUs, presented last week at...
...T. LAUDERDALE, Fla., April 13 MEDmarketplace.co...me a member of its Board of Directors. MEDmarketpl...based marketplace for buying and selling surplus ...Health Alliance and Premier, Inc, that has a major...
... NEW YORK, April 13 The Advertising Council, in...he launch of a new series of public,service advert...e Els, and his,six year old son, Ben, designed to ...ildren. , , To view the Multimedia News Release...
Other Medicine News:Health News:Awareness of Alternative Therapies May Be Lacking 2Health News:Pharoah's Wine Jar Yields Medicinal Secrets 2Health News:Pharoah's Wine Jar Yields Medicinal Secrets 3Health News:Fish researcher demonstrates first 'non-visual feeding' by African cichlids 2Health News:Resurrection Health Uses Information Technology to Address Critical Care Crisis 2Health News:Alan Weinstein Joins the Board of Directors at MEDmarketplace.com 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 4
(Date:12/2/2009)...ec. 2 Hospira, Inc. (NYS...tion and medication delivery technologies, announc... TheraDoc, a clinical informatics company that dev...o leading products, Infection Control Assistant(TM...anding portfolio of medication safety and infectio...
(Date:12/2/2009)...YORK, Dec. 2 Interleukin... Medical Center announced findings from a study pe...he genetics of osteoarthritis have been published ...als of Rheumatic Diseases and is available at htt... . Results from the study highlight importance...
(Date:12/2/2009)...RNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NV... the first stage of a two-stage pivotal Phase II s...he company,s 2009 H1N1 virus-like particle (VLP) p...this study in collaboration with Avimex Laboratori...e in Mexico and potentially other countries. ,,...
Breaking Medicine Technology:Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 4Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 5Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48 Year Exemplary Record of Quality 54443 1Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48 Year Exemplary Record of Quality 54443 2Two Texas Dental Students Receive One time Scholarships from United Concordia Dental 54440 1Two Texas Dental Students Receive One time Scholarships from United Concordia Dental 54440 2Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry 54437 1Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry 54437 2
... 28 Aida,Pharmaceuticals, Inc. (OTC Bulletin Boar...essfully completed Phase II field testing of its,a...ecade of research,Rh-Apo2L is intended to be a new... by genetic engineering. The drug is designed as a...ancer cells. Assuming successful,completion of all...
...Phase III Program in First Half of 2008, LEXINGTO...Nasdaq: IDEV ) today announced positive results f...nts with acromegaly, a,disorder characterized by e...nsulin- like growth factor 1 (IGF-1). The implant ...to deliver effective levels of octreotide for,six ...
Other Medicine Technology:Aida Announces Completion of Anti-Cancer Drug Phase Two Testing 2Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial 2Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial 3Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial 4Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial 5
...sist is a custom wrist orthotic designed to limit ... the patient's maximum range-of-motion. It incorpo...n-resistance attachment. , ,Indications: , Wrist...riangular fibrocartilage complex , Coles fractur...
Universal Wrist/Forearm Splint
Suede Wrist Lacer Splint
Westport Lacing Wrist Brace
Medicine Products: